Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Frank: Studies to Maximize Immunogenicity |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Guinea Pig |
| Stage: | Assays Completed |
| Study Start Date: | 2015-12-15 |
| Study Made Public: | 2016-10-31 |
Title
Studies to maximize immunogenicity by Env trimer stabilization and complement activation
Description
CAVD 535 is pre-clinical guinea pig study evaluating neutralizing antibodies following BG505 SOSOIP gp140 and JRFL gp140 protein regimens.
Sign in to see full information about this study and to download study data.
Products
B-glucan JRFL gp140 BG505 SOSIP - crosslinker BG505 SOSIP - crosslinker/glycosidase JRFL gp140 - crosslinkerIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.